$23.30
0.803.53%
Last update: Oct 29, 9:51 AM
Rapport Therapeutics Inc (RAPP) Stock Price, Quote, News & History
RAPPNASDAQ
U.S. stock futures mixed as Enphase plunges 17% after earnings and weak guidance; Rapport, Intapp, Logitech and others also fall premarket.
You can purchase shares of Rapport Therapeutics (NASDAQ:RAPP) through any online brokerage.
Other companies in Rapport Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Rapport Therapeutics has a consensus price target of $57.71.
The stock price for Rapport Therapeutics (NASDAQ: RAPP) is $23.295 last updated October 29, 2026 at 9:51 AM EDT.
There are no upcoming dividends for Rapport Therapeutics.
Rapport Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Rapport Therapeutics.
Rapport Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its...
